CN102370617A - 石杉碱甲眼用微乳制剂及其制备方法 - Google Patents
石杉碱甲眼用微乳制剂及其制备方法 Download PDFInfo
- Publication number
- CN102370617A CN102370617A CN2010102533498A CN201010253349A CN102370617A CN 102370617 A CN102370617 A CN 102370617A CN 2010102533498 A CN2010102533498 A CN 2010102533498A CN 201010253349 A CN201010253349 A CN 201010253349A CN 102370617 A CN102370617 A CN 102370617A
- Authority
- CN
- China
- Prior art keywords
- huperzine
- agent
- microemulsion
- preparation according
- ocular microemulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
对比实施例3(石杉碱甲滴眼溶液剂) | |
石杉碱甲 | 50mg |
渗透压调节剂 | 氯化钠6.2g |
抑菌剂 | 尼泊金乙酯0.3g |
离子对试剂 | 山梨酸1g |
增稠剂 | 羧甲基纤维素钠1g |
pH调节剂 | 氢氧化钠0.1M-盐酸0.1M |
纯化水 | 加至1000mL |
制剂pH值 | 7.05 |
粘度 | 1.86cp |
Claims (13)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102533498A CN102370617B (zh) | 2010-08-13 | 2010-08-13 | 石杉碱甲眼用微乳制剂及其制备方法 |
PCT/CN2011/001350 WO2012019439A1 (zh) | 2010-08-13 | 2011-08-12 | 石杉碱甲眼用微乳制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102533498A CN102370617B (zh) | 2010-08-13 | 2010-08-13 | 石杉碱甲眼用微乳制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102370617A true CN102370617A (zh) | 2012-03-14 |
CN102370617B CN102370617B (zh) | 2013-09-11 |
Family
ID=45567323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102533498A Active CN102370617B (zh) | 2010-08-13 | 2010-08-13 | 石杉碱甲眼用微乳制剂及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102370617B (zh) |
WO (1) | WO2012019439A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726479A (zh) * | 2016-03-24 | 2016-07-06 | 北京茗泽中和药物研究有限公司 | 环孢素眼用乳剂 |
CN107582605A (zh) * | 2016-07-07 | 2018-01-16 | 萨尔瓦特实验室股份有限公司 | 眼用组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621039A (zh) * | 2003-11-25 | 2005-06-01 | 上海医药工业研究院 | 石杉碱甲及其衍生物或其盐的经鼻脑靶向制剂 |
CN101797223A (zh) * | 2009-02-06 | 2010-08-11 | 上海交通大学医学院 | 石杉碱甲眼用制剂及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379688B2 (en) * | 1997-02-28 | 2002-04-30 | Senju Pharmaceutical Co., Ltd. | Preservative for emulsion and emulsion containing same |
CN101797252A (zh) * | 2009-02-06 | 2010-08-11 | 上海交通大学医学院 | 石杉碱甲在制药中的应用 |
-
2010
- 2010-08-13 CN CN2010102533498A patent/CN102370617B/zh active Active
-
2011
- 2011-08-12 WO PCT/CN2011/001350 patent/WO2012019439A1/zh active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621039A (zh) * | 2003-11-25 | 2005-06-01 | 上海医药工业研究院 | 石杉碱甲及其衍生物或其盐的经鼻脑靶向制剂 |
CN101797223A (zh) * | 2009-02-06 | 2010-08-11 | 上海交通大学医学院 | 石杉碱甲眼用制剂及其应用 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726479A (zh) * | 2016-03-24 | 2016-07-06 | 北京茗泽中和药物研究有限公司 | 环孢素眼用乳剂 |
CN105726479B (zh) * | 2016-03-24 | 2018-06-22 | 北京茗泽中和药物研究有限公司 | 环孢素眼用乳剂 |
CN107582605A (zh) * | 2016-07-07 | 2018-01-16 | 萨尔瓦特实验室股份有限公司 | 眼用组合物 |
Also Published As
Publication number | Publication date |
---|---|
WO2012019439A1 (zh) | 2012-02-16 |
CN102370617B (zh) | 2013-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102159186B (zh) | 氟比洛芬酯眼用纳米乳-原位凝胶制剂及其制备方法 | |
US20070167526A1 (en) | Topical mecamylamine formulations for ocular administration and uses thereof | |
US20110275715A1 (en) | Method for treating retinal disease | |
JP2023179418A (ja) | 近視の進行を制御し且つ/又は減少させるための医薬組成物 | |
JP6407145B2 (ja) | 網脈絡膜障害の抑制剤 | |
CN102370617B (zh) | 石杉碱甲眼用微乳制剂及其制备方法 | |
CN101797223B (zh) | 石杉碱甲眼用制剂及其应用 | |
CN101232902B (zh) | 使用固态组合物的对后眼部组织的非侵袭性药物传递*** | |
CN102085175B (zh) | 一种眼用凝胶剂及其制备方法 | |
CN107412211A (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
CN110833526B (zh) | 一种防治青少年近视的眼用制剂及其制备方法 | |
CN104324038A (zh) | 一种薯蓣皂苷元-3-位衍生物的用途 | |
US20120087864A1 (en) | Method for diagnosing and/or evaluating retinal disease | |
CN103977011A (zh) | 含有曲伏前列素和噻吗洛尔的眼用凝胶剂及其制备方法 | |
CN102920722A (zh) | 治疗眼底病的眼用制剂 | |
CN100584332C (zh) | 含有粉防己碱的眼用制剂及其在制备治疗眼科疾病的含有粉防己碱的眼用制剂中的应用 | |
CN112263545B (zh) | 一种眼用组合物及其制备方法与应用 | |
CA3088185C (en) | Suspension compositions of multi-target inhibitors | |
US20210401919A1 (en) | Ophthalmic Compositions | |
KR20230098630A (ko) | 노안의 예방, 제어 및 근절에 효과적인 저농도 투여량의 상승적 안과 조성물 | |
CN107714709B (zh) | 七叶皂苷及其盐在制备治疗白内障药物中的用途 | |
CN111437252B (zh) | 一种含有灯盏细辛提取物的眼用制剂、制备方法及应用 | |
CN111450044B (zh) | 一种含有灯盏乙素的眼用制剂、制备方法及其应用 | |
CN102018656A (zh) | 含有效成分拉坦前列素的眼用凝胶剂及其制备方法 | |
CN108853013B (zh) | 一种滴眼液及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HE WEI Effective date: 20150506 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200031 XUHUI, SHANGHAI TO: 201203 PUDONG NEW AREA, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150506 Address after: 201203 Shanghai city Zuchongzhi road Pudong New Area Zhangjiang hi tech Park No. 555 Patentee after: Shanghai Institute of Materia Medica, Chinese Academy of Sciences Patentee after: He Wei Address before: 200031 No. 294, Taiyuan Road, Shanghai Patentee before: Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200304 Address after: 200124 No. 555, Zuchongzhi Road, Zhangjiang, Pudong New Area, Shanghai Co-patentee after: Shenyang He's Eye Industry Group Co., Ltd. Patentee after: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Address before: 201203 Shanghai city Zuchongzhi road Pudong New Area Zhangjiang hi tech Park No. 555 Co-patentee before: He Wei Patentee before: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES |